Cristiane D Bergerot, Former Postdoc Fellow and Research Consultant at City of Hope, shared a post on X:
“Honored to be part of this Society for Immunotherapy of Cancer (SITC) guideline on IO for kidney cancer.
This work offers evidence and consensus based recommendations for adjuvant and metastatic RCC, special populations, response monitoring, and patient education and quality of life”
Laura Bukavina, Urologic Oncologist at Cleveland Clinic and Assistant Professor of Urologic Oncology at Case Western Reserve University, shared a post by Cristiane D Bergerot, adding:
“I couldn’t agree more. This guideline is a fantastic example of exceptional leadership. Kudos to Rana McKay, and Sumanta K. Pal for bringing us together and for ensuring meaningful inclusion of multi D team.”
Title: Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of renal cell carcinoma, version 3.0
Authors: Rana R McKay, Archana Ajmera, Michael B Atkins, Pedro C Barata, Cristiane Bergerot, Laura Bukavina, Toni K Choueiri, Arpita Desai, A Ari Hakimi, Susan Poteat, Thomas Powles, Brian I Rini, Brian Shuch, Sabina Signoretti, Shankar Siva, Wenxin Xu, Wesley Yip, Tian Zhang and Sumanta K Pal
Other articles featuring Laura Bukavina and Cristiane D Bergerot on OncoDaily.
